CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-07 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2024-03-07 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +94,441 | 94,441 | ||
| 2023-10-04 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +370,282 | 370,282 | ||
| 2023-10-04 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +210,225 | 210,225 | ||
| 2023-10-04 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +191,113 | 191,113 | ||
| 2023-10-04 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +210,225 | 210,225 | ||
| 2023-10-04 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +358,337 | 358,337 | ||
| 2023-10-04 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +372,671 | 372,671 | ||
| 2023-10-04 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +286,670 | 286,670 | ||
| 2023-04-20 | Dagnon Terry Chief Operations Officer | Sale | −520,000 | $1.14 | $590K | 653,058 |
| 2023-04-17 | Dagnon Terry Chief Operations Officer | Grant or award · Stock Option (Right to Buy) | +192,143 | 192,143 | ||
| 2023-04-17 | Evanson Jeff Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +192,143 | 192,143 | ||
| 2023-04-17 | TRENARY C RUSSELL III CEO and President | Grant or award · Stock Option (Right to Buy) | +257,143 | 257,143 | ||
| 2023-03-29 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +41,065 | 41,065 | ||
| 2023-03-29 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +41,065 | 41,065 | ||
| 2023-03-29 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +41,065 | 41,065 |
Page 5 of 8 · 142 trades